FDA Inspection
OneBlood, Inc.OneBlood, Inc. – FDA Inspection, Jun 18, 2010
Record Details
This FDA Inspection record concerns OneBlood, Inc., with an inspection on June 18, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- OneBlood, Inc.
- Inspection Date
- June 18, 2010
- Product Type
- Biologics
View Company Profile
ID · 05da8d33-7bab-4261-aadd-2e1529af556c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 668081
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 640.3(f)Donations in less than eight weeks
- 21 CFR 606.20(b)Qualifications of responsible personnel
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of OneBlood, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| January 9, 2026 | Not classified | Atlanta District Office | Blood and Blood Products |
| May 16, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 22, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 31, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 18, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for OneBlood, Inc.
- FDA Inspection 1297970 - 2026-01-09
- FDA Inspection 1170316 - 2022-05-16
- FDA Inspection 1067954 - 2018-06-22
- FDA Inspection 966465 - 2016-03-31
- FDA Inspection 895927 - 2014-09-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.